Department of Psychology, University of Illinois at Urbana-Champaign, Champaign.
Department of Psychology, University of Denver, Denver, Colorado.
JAMA Psychiatry. 2023 Jun 1;80(6):539-547. doi: 10.1001/jamapsychiatry.2023.0702.
Prenatal depression is prevalent with negative consequences for both the mother and developing fetus. Brief, effective, and safe interventions to reduce depression during pregnancy are needed.
To evaluate depression improvement (symptoms and diagnosis) among pregnant individuals from diverse backgrounds randomized to brief interpersonal psychotherapy (IPT) vs enhanced usual care (EUC).
DESIGN, SETTING, AND PARTICIPANTS: A prospective, evaluator-blinded, randomized clinical trial, the Care Project, was conducted among adult pregnant individuals who reported elevated symptoms during routine obstetric care depression screening in general practice in obstetrics and gynecology (OB/GYN) clinics. Participants were recruited between July 2017 and August 2021. Repeated measures follow-up occurred across pregnancy from baseline (mean [SD], 16.7 [4.2] gestational weeks) through term. Pregnant participants were randomized to IPT or EUC and included in intent-to-treat analyses.
Treatment comprised an engagement session and 8 active sessions of brief IPT (MOMCare) during pregnancy. EUC included engagement and maternity support services.
Two depression symptom scales, the 20-item Symptom Checklist and the Edinburgh Postnatal Depression Scale, were assessed at baseline and repeatedly across pregnancy. Structured Clinical Interview for DSM-5 ascertained major depressive disorder (MDD) at baseline and the end of gestation.
Of 234 participants, 115 were allocated to IPT (mean [SD] age, 29.7 [5.9] years; 57 [49.6%] enrolled in Medicaid; 42 [36.5%] had current MDD; 106 [92.2%] received intervention) and 119 to EUC (mean [SD] age, 30.1 [5.9] years; 62 [52.1%] enrolled in Medicaid; 44 [37%] had MDD). The 20-item Symptom Checklist scores improved from baseline over gestation for IPT but not EUC (d = 0.57; 95% CI, 0.22-0.91; mean [SD] change for IPT vs EUC: 26.7 [1.14] to 13.6 [1.40] vs 27.1 [1.12] to 23.5 [1.34]). IPT participants more rapidly improved on Edinburgh Postnatal Depression Scale compared with EUC (d = 0.40; 95% CI, 0.06-0.74; mean [SD] change for IPT vs EUC: 11.4 [0.38] to 5.4 [0.57] vs 11.5 [0.37] to 7.6 [0.55]). MDD rate by end of gestation had decreased significantly for IPT participants (7 [6.1%]) vs EUC (31 [26.1%]) (odds ratio, 4.99; 95% CI, 2.08-11.97).
In this study, brief IPT significantly reduced prenatal depression symptoms and MDD compared with EUC among pregnant individuals from diverse racial, ethnic, and socioeconomic backgrounds recruited from primary OB/GYN clinics. As a safe, effective intervention to relieve depression during pregnancy, brief IPT may positively affect mothers' mental health and the developing fetus.
ClinicalTrials.gov Identifier: NCT03011801.
产前抑郁症在母亲和胎儿发育中都很普遍,且后果严重。需要有简短、有效且安全的干预措施来减少怀孕期间的抑郁。
评估来自不同背景的孕妇在接受简短人际治疗(IPT)与强化常规护理(EUC)后抑郁改善情况(症状和诊断)。
设计、设置和参与者:前瞻性、评估者盲法、随机临床试验 Care Project 在妇产科诊所的常规产科护理抑郁筛查中报告存在升高症状的成年孕妇中进行。参与者于 2017 年 7 月至 2021 年 8 月期间招募。从基线(平均[SD],16.7[4.2]妊娠周)到足月妊娠,通过重复测量对孕妇进行随访。孕妇随机分配到 IPT 或 EUC 组,并进行意向治疗分析。
治疗包括在怀孕期间进行一次参与会议和 8 次简短 IPT(MOMCare)的主动治疗。EUC 包括参与和产妇支持服务。
在基线和整个妊娠期间重复评估了两个抑郁症状量表,即 20 项症状清单和爱丁堡产后抑郁量表。使用 DSM-5 结构化临床访谈在基线和孕期末确定了重度抑郁症(MDD)。
在 234 名参与者中,115 名被分配到 IPT(平均[SD]年龄 29.7[5.9]岁;57 名[49.6%]参加了医疗补助计划;42 名[36.5%]患有当前 MDD;106 名[92.2%]接受了干预),119 名被分配到 EUC(平均[SD]年龄 30.1[5.9]岁;62 名[52.1%]参加了医疗补助计划;44 名[37%]患有 MDD)。IPT 组的 20 项症状清单评分从基线到妊娠期间有所改善,但 EUC 组没有(d=0.57;95%CI,0.22-0.91;IPT 与 EUC 组的平均[SD]变化:26.7[1.14]至 13.6[1.40],27.1[1.12]至 23.5[1.34])。与 EUC 相比,IPT 组在爱丁堡产后抑郁量表上的改善速度更快(d=0.40;95%CI,0.06-0.74;IPT 与 EUC 组的平均[SD]变化:11.4[0.38]至 5.4[0.57],11.5[0.37]至 7.6[0.55])。IPT 组的 MDD 发生率在孕期末显著下降(7[6.1%]),而 EUC 组为 31[26.1%])(比值比,4.99;95%CI,2.08-11.97)。
在这项研究中,在来自初级妇产科诊所招募的具有不同种族、民族和社会经济背景的孕妇中,简短的 IPT 与 EUC 相比,显著降低了产前抑郁症状和 MDD。作为一种安全有效的缓解怀孕期间抑郁的干预措施,简短的 IPT 可能会对母亲的心理健康和发育中的胎儿产生积极影响。
ClinicalTrials.gov 标识符:NCT03011801。